News Corporation Free cash flow increased by 202.3% to $399.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.5%, from $418.00M to $399.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -9.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.00M | -$33.00M | $255.00M | $493.00M | $140.00M | -$135.00M | $79.00M | $376.00M | $425.00M | -$179.00M | $330.00M | $447.00M | $143.00M | -$11.00M | $132.00M | $418.00M | $32.00M | $4.00M | $132.00M | $399.00M |
| QoQ Change | — | -182.5% | +872.7% | +93.3% | -71.6% | -196.4% | +158.5% | +375.9% | +13.0% | -142.1% | +284.4% | +35.5% | -68.0% | -107.7% | >999% | +216.7% | -92.3% | -87.5% | >999% | +202.3% |
| YoY Change | — | — | — | — | +250.0% | -309.1% | -69.0% | -23.7% | +203.6% | -32.6% | +317.7% | +18.9% | -66.4% | +93.9% | -60.0% | -6.5% | -77.6% | +136.4% | +0.0% | -4.5% |